Prothena Corporation plc (NASDAQ:PRTA), a late-stage clinical biotechnology company with a robust pipeline of investigational therapeutics built on protein dysregulation expertise, today announced ...
Proven immunology-focused executive and physician-scientist who has led companies from inception to IPO, driven multiple ...
The biotechnology company reported a profit of $1.82 billion, driven by a 4% rise in product sales.
CNTY-813 is an iPSC-derived islet cell replacement therapy engineered with Allo-Evasion™ 5.0 for patients with type 1 diabetes; on track for IND submission in 4Q 2026 ...
Spyre Therapeutics Inc. (NASDAQ:SYRE) is one of the small-cap stocks that are on fire right now. On April 16, Spyre ...
Hemab Therapeutics Holdings has increased the size of its planned initial public offering to 15 million shares from nearly 11.8 million. Hemab on Thursday said it still expects an IPO pricing of $16 ...
Central Ohio is a growing U.S. biotech hub because of decades of efforts, the head of a national trade group says.
When we treat cancer patients, their disease can overcome treatment through its innate capacity to adapt. This is at the ...
Discover how preferred provider organizations (PPOs) work, their benefits over HMOs, and why they might be the right health ...
PBM reform championed by Sen. Warner is a necessary step to lower health care costs for patients, VA Bio’s John Newby writes in a guest column ...
As a fledgling researcher in the United States, Zhang Li was struck by the efficiency of extracting human tissue in the morning and mining it for data the same afternoon.
The prices of mineral fertilizers are rising. The Fraunhofer Institute for Interfacial Engineering and Biotechnology IGB is ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results